Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

American Journal of Epidemiology

Volumn 162, Issue 4, 2005, Pages 305-317

  Lehmann, Donald J ^a   Cortina Borja, Mario ^b   Warden, Donald R ^a   Smith, A David ^a   Sleegers, Kristel ^c   Prince, Jonathan A ^d   Van Duijn, Cornelia M ^c   Kehoe, Patrick G ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alzheimer disease; Heterogeneity; Meta analysis

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E EPSILON4; DIPEPTIDYL CARBOXYPEPTIDASE; UNCLASSIFIED DRUG; APOLIPOPROTEIN E4;

EPIDEMIOLOGICAL PHENOMENA;

AGE DISTRIBUTION; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; ASIAN; CAUCASIAN; CONTROLLED STUDY; DISEASE MARKER; ETHNIC GROUP; GENDER; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HETEROSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; METHODOLOGY; RISK REDUCTION; CLINICAL TRIAL; CONFIDENCE INTERVAL; FEMALE; GENETICS; MALE; META ANALYSIS; MIDDLE AGED; REVIEW;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CONFIDENCE INTERVALS; ETHNIC GROUPS; FEMALE; HUMANS; HYBRID VIGOR; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC;

EID: 23944438473     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwi202     Document Type: Article

References (79)

1. Kehoe PG, Russ C, Mcllroy S, et al. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet 1999;21:71-2.
2. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
3. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992;51:197-205.
4. Nacmias B, Tedde A, Forleo P, et al. Angiotensin converting enzyme polymorphism in sporadic and presenilin-linked Alzheimer's disease families. (Abstract). Neurology 1999;52(suppl 2):A323.
5. Wakutani Y, Kowa H, Kusumi M, et al. Genetic analysis of vascular factors in Alzheimer's disease. Ann N Y Acad Sci 2002;977:232-8.
6. Farrer LA, Sherbatich T, Keryanov SA, et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol 2000;57:210-14.
7. Crawford F, Abdullah L, Schinka J, et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease. Neurosci Lett 2000;280:215-19.
8. Kehoe PG, Katzov H, Andreasen N, et al. Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Hum Genet 2004;114:478-83.
9. Sleegers K, den Heijer T, van Dijk EJ, et al. ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala. Neurobiol Aging 2005;26:1153-9.
10. Narain Y, Yip A, Murphy T, et al. The ACE gene and Alzheimer's disease susceptibility. J Med Genet 2000;37:695-7.
11. Kehoe PG, Katzov H, Feuk L, et al. Haplotypes extending across ACE are associated with Alzheimer's disease. Hum Mol Genet 2003;12:859-67.
12. Elkins JS, Douglas VC, Johnston SC. Alzheimer disease risk and genetic variation in ACE. A meta-analysis. Neurology 2004;62:363-8.
13. Camelo D, Arboleda G, Yunis JJ, et al. Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients. J Neurol Sci 2004;218:47-51.
14. Fernández-Novoa L, Lombardi VRM, Seoane S, et al. The ACE gene in Alzheimer's disease. In: Hanin I, Fisher A, Cacabelos R, eds. New trends in Alzheimer and Parkinson related disorders. Bologna, Italy: Monduzzi Editore, 2004: 123-6.
15. Keikhaee MR, Najmabadi H, Pasalar P. Angiotensin-converting enzyme and apolipoprotein E genotype in Alzheimer's disease in Iranian population. (Abstract). Neurobiol Aging 2002;23(suppl):S404.
16. Lendon CL, Thaker U, Harris JM, et al. The angiotensin 1-converting enzyme insertion (I)/deletion (D) polymorphism does not influence the extent of amyloid or tau pathology in patients with sporadic Alzheimer's disease. Neurosci Lett 2002;328:314-18.
17. Panza F, Solfrizzi V, D'Introno A, et al. Lack of association between ACE polymorphism and Alzheimer's disease in southern Italy. Arch Gerontol Geriatr Suppl 2002;8:239-45.
18. Seripa D, Dal Forno G, Matera MG, et al. Methylenetetra-hydrofolate reductase and angiotensin converting enzyme gene polymorphisms in two genetically and diagnostically distinct cohorts of Alzheimer patients. Neurobiol Aging 2003;24:933-9.
19. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 1997;278:1349-56.
20. Lehmann DJ, Williams J, McBroom J, et al. Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer's disease and to identify high-risk subgroups. Neuroscience 2001;108:541-54.
21. Egger M, Davey Smith G, Altman DGE. Systematic reviews in health care: meta-analysis in context. London, United Kingdom: BMJ Books, 2001.
22. Ott A, Breteler MM, van Harskamp F, et al. Incidence and risk of dementia. The Rotterdam Study. Am J Epidemiol 1998;147:574-80.
23. Prince JA, Feuk L, Sawyer SL, et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-44.
24. Prince J, Feuk L, Brookes A, et al. Genetic variation in ACE influences the severity of Alzheimer's disease. (Abstract). Neurobiol Aging 2002;23(suppl):S319.
25. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
26. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-44.
27. Fogarty DG, Maxwell AP, Doherty CC, et al. ACE gene typing. (Letter). Lancet 1994;343:851.
28. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993;3:120-1.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
31. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002;21:1601-23.
32. Armitage P. Statistical methods in medical research. Oxford, United Kingdom: Blackwell Scientific Publications, 1983.
33. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
34. Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Eng J Med 1992;327:248-54.
35. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
36. Cox R, Bouzekri N, Martin S, et al. Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum Mol Genet 2002;11:2969-77.
37. Katzov H, Bennet AM, Kehoe P, et al. A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity. Hum Mol Genet 2004;13:2647-57.
38. Nagy Z, Esiri MM, Hindley NJ, et al. Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dement Geriatr Cogn Disord 1998;9:219-26.
39. Panza F, Solfrizzi V, D'Introno A, et al. Shifts in angiotensin 1 converting enzyme insertion allele frequency across Europe: implications for Alzheimer's disease risk. J Neurol Neurosurg Psychiatry 2003;74:1159-61.
40. Buss S, Müller-Thomsen T, Hock C, et al. No association between DCP1 genotype and late-onset Alzheimer disease. Am J Med Genet 2002;114:440-5.
41. Perry RT, Collins JS, Harrell LE, et al. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001;105:332-42.
42. Comings DE, MacMurray JP. Molecular heterosis: a review. Mol Genet Metab 2000;71:19-31.
43. Samani NJ, Thompson JR, O'Toole L, et al. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996;94:708-12.
44. Staessen JA, Wang JG, Ginocchio G, et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997;15:1579-92.
45. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry 1998;64:227-30.
46. Keavney B, McKenzie C, Parish S, et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet 2000;355:434-42.
47. Sayed-Tabatabaei FA, Houwing-Duistermaat JJ, van Duijn CM, et al. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness. A meta-analysis. Stroke 2003;34:1634-9.
48. Arregui A, Perry EK, Rossor M, et al. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J Neurochem 1982;38:1490-2.
49. Barnes NM, Cheng CH, Costall B, et al. Angiotensin converting enzyme density is increased in temporal cortex from patients with Alzheimer's disease. Eur J Pharmacol 1991;200:289-92.
50. Savaskan E, Hock C, Olivieri G, et al. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia. Neurobiol Aging 2001;22:541-6.
51. Hu J, Igarashi A, Kamata M, et al. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (Ab); retards Ab aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem 2001;276:47863-8.
52. Hirawa N, Uehara Y, Kawabata Y, et al. Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. Hypertension 1999;34:496-502.
53. Sudilovsky A, Turnbull B, Croog SH, et al. Angiotensin converting enzyme and memory: preclinical and clinical data. Int J Neurol 1987-88;21-22:145-62.
54. Ohrui T, Matsui T, Yamaya M, et al. Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J Am Geriatr Soc 2004;52:649-50.
55. Ohrui T, Tomita N, Sato-Nakagawa T, et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology 2004;63:1324-5.
56. Kehoe PG. The renin-angiotensin-aldosterone system and Alzheimer's disease? J Renin Angiotensin Aldosterone Syst 2003;4:80-93.
57. Agerholm-Larsen B, Nordestgaard BG, Steffensen R, et al. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation 1997;95:2358-67.
58. Galinsky D, Tysoe C, Brayne CE, et al. Analysis of the apoe E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis 1997;129:177-83.
59. Shimokata H, Yamada Y, Nakagawa M, et al. Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol 2000;10(suppl):S46-55.
60. Blanché H, Cabanne L, Sahbatou M, et al. A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 2001;324:129-35.
61. Panza F, Solfrizzi V, D'Introno A, et al. Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe. Exp Gerontol 2003;38:1015-20.
62. Da Cruz IB, Oliveira G, Taufer M, et al. Angiotensin I-converting enzyme gene polymorphism in two ethnic groups living in Brazil's southern region: association with age. J Gerontol A Biol Sci Med Sci 2003;58:M851-6.
63. Alvarez R, Alvarez V, Lahoz CH, et al. Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1999;67:733-6.
64. Carbonell J, Allen R, Kalsi G, et al. Variation in the DCP1 gene, encoding the angiotensin converting enzyme ACE, is not associated with increased susceptibility to Alzheimer's disease. Psychiatr Genet 2003;13:47-50.
65. Chapman J, Wang N, Treves TA, et al. ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. Stroke 1998;29:1401-4.
66. Cheng CY, Hong CJ, Liu HC, et al. Study of the association between Alzheimer's disease and angiotensin-converting enzyme gene polymorphism using DNA from lymphocytes. Eur Neurol 2002;47:26-9.
67. Hu J, Miyatake F, Aizu Y, et al. Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population. Neurosci Lett 1999;277:65-7.
68. Isbir T, Agaçhan B, Yilmaz H, et al. Angiotensin converting enzyme gene polymorphism in Alzheimer's disease. Cell Biochem Funct 2000;18:141-2.
69. Mattila KM, Rinne JO, Röyttä M, et al. Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E ε4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with co-existing Alzheimer pathology. J Med Genet 2000;37:766-70.
70. Monastero R, Caldarella R, Mannino M, et al. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci Lett 2002;335:147-9.
71. Myllykangas L, Polvikoski T, Sulkava R, et al. Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over. Neurosci Lett 2000;292:195-8.
72. Palumbo B, Cadini D, Nocentini G, et al. Angiotensin converting enzyme deletion allele in different kinds of dementia disorders. Neurosci Lett 1999;267:97-100.
73. Richard F, Fromentin-David I, Ricolfi F, et al. The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 2001;56:1593-5.
74. Scacchi R, De Bernardini L, Mantuano E, et al. DNA polymorphisms of apolipoprotein B and angiotensin 1-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer's disease. Dement Geriatr Cogn Disord 1998;9:186-90.
75. Wu C, Zhou D, Guan Z, et al. The association between angiotensin I converting enzyme gene polymorphism and Chinese late onset Alzheimer disease. (In Chinese). Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:401-4.
76. Yang JD, Feng G, Zhang J, et al. Association between angiotensin- converting enzyme gene and late onset Alzheimer's disease in Han Chinese. Neurosci Lett 2000;295:41-4.
77. Zuliani G, Ble' A, Zanca R, et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 2001;103:304-8.
78. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association, 1994.
79. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.